Annual report pursuant to Section 13 and 15(d)

Statement of Stockholder's Equity

v2.4.0.6
Statement of Stockholder's Equity (USD $)
 11 Months Ended
Dec. 31, 2011
Underwriters' discount and offering expenses $ (11,140,311)
Proceeds from private placement of 7,000,000 warrants on May 18, 2011 5,250,000
Proceeds subject to possible redemption of 17,856,407 shares (178,278,367)
Net loss (781,319)
Ending Balances 5,000,003
Issuance During Period 1st | Sponsor
  
Sale of common stock 25,000
Issuance During Period 2nd | IPO
  
Sale of common stock 189,925,000
Common Stock
  
Forfeiture of common stock issued to Sponsor(in shares) (248,598)
Forfeiture of common stock issued to Sponsor (25)
Ending Balances (in shares) 23,161,585
Ending Balances 2,316
Common Stock | Issuance During Period 1st | Sponsor
  
Sale of common stock (in shares) 4,417,683
Sale of common stock 442
Common Stock | Issuance During Period 2nd | IPO
  
Sale of common stock (in shares) 18,992,500
Sale of common stock 1,899
Additional Paid-in Capital
  
Underwriters' discount and offering expenses (11,140,311)
Proceeds from private placement of 7,000,000 warrants on May 18, 2011 5,250,000
Proceeds subject to possible redemption of 17,856,407 shares (178,278,367)
Forfeiture of common stock issued to Sponsor 25
Ending Balances 5,779,006
Additional Paid-in Capital | Issuance During Period 1st | Sponsor
  
Sale of common stock 24,558
Additional Paid-in Capital | Issuance During Period 2nd | IPO
  
Sale of common stock 189,923,101
Deficit Accumulated During the Development Stage
  
Net loss (781,319)
Ending Balances $ (781,319)